» Articles » PMID: 3086234

Natural and Recombinant Interferons Inhibit Epithelial Cell Invasion by Shigella Spp

Overview
Journal Infect Immun
Date 1986 Jun 1
PMID 3086234
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of natural and recombinant interferons (IFNs) on the abilities of Shigella flexneri, S. sonnei, and Salmonella typhimurium to invade different human and murine cells was examined. Pretreatment of cell monolayers with natural and recombinant IFNs reduced the number of Shigella-infected cells in a dose-dependent manner. Establishment of an anti-invasive cellular state was time dependent, requiring 10 h for 50% inhibition of bacterial invasion. The inhibitory effect of IFN was species specific, with human or murine IFN effective against homologous but not heterologous cells. Gamma IFN was slightly more potent than alpha IFN at inhibiting bacterial invasion. Inhibition of Shigella invasion was dependent on the challenge dose of bacteria. Little inhibition of invasion was seen when cells were pretreated with low concentrations of IFN and challenged with high multiplicities of infection of Shigella sp. In contrast to Shigella invasion, the maximum inhibitory effect of IFN on Salmonella invasion of cells was observed at low levels (5 to 50 U) of IFN. These results suggest that Shigella and Salmonella invasions occur at unique sites on eucaryotic cells or by different penetration mechanisms. More importantly, these data suggest that IFN may play a significant role in host defense against Shigella and Salmonella infections.

Citing Articles

Impact of STING Inflammatory Signaling during Intracellular Bacterial Infections.

Guimaraes E, Marinho F, de Queiroz N, Antunes M, Oliveira S Cells. 2022; 11(1).

PMID: 35011636 PMC: 8750390. DOI: 10.3390/cells11010074.


Interferons: Tug of War Between Bacteria and Their Host.

Alphonse N, Dickenson R, Odendall C Front Cell Infect Microbiol. 2021; 11:624094.

PMID: 33777837 PMC: 7988231. DOI: 10.3389/fcimb.2021.624094.


Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation.

Kienes I, Weidl T, Mirza N, Chamaillard M, Kufer T Int J Mol Sci. 2021; 22(3).

PMID: 33525590 PMC: 7865845. DOI: 10.3390/ijms22031301.


The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro.

Helbig K, Teh M, Crosse K, Monson E, Smith M, Tran E Sci Rep. 2019; 9(1):15598.

PMID: 31666594 PMC: 6821890. DOI: 10.1038/s41598-019-52130-8.


A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.

Davis C, Wahid R, Toapanta F, Simon J, Sztein M PLoS One. 2018; 13(1):e0189571.

PMID: 29304144 PMC: 5755796. DOI: 10.1371/journal.pone.0189571.


References
1.
Prizont R . Degradation of intestinal glycoproteins by pathogenic Shigella flexneri. Infect Immun. 1982; 36(2):615-20. PMC: 351273. DOI: 10.1128/iai.36.2.615-620.1982. View

2.
Pace J, RUSSELL S, Schreiber R, Altman A, Katz D . Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc Natl Acad Sci U S A. 1983; 80(12):3782-6. PMC: 394136. DOI: 10.1073/pnas.80.12.3782. View

3.
Reisbig R, Olsnes S, Eiklid K . The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem. 1981; 256(16):8739-44. View

4.
Mackaness G . The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969; 129(5):973-92. PMC: 2138649. DOI: 10.1084/jem.129.5.973. View

5.
Sansonetti P, Kopecko D, Formal S . Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982; 35(3):852-60. PMC: 351125. DOI: 10.1128/iai.35.3.852-860.1982. View